Navigation Links
Antiviral Therapy May Cut Recurrence of Hepatitis B-Linked Liver Cancer
Date:11/12/2012

ociated with about a third less risk, and the use of painkillers such as aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) was associated with a 20 percent reduced risk.

The study, published online Nov. 12 in the Journal of the American Medical Association, also was scheduled for presentation Monday at the annual meeting of the American Association for the Study of Liver Diseases, in Boston.

Bernstein cautioned that, in his opinion, the study had some flaws.

"The most important is the lack of data regarding the hepatitis B viral load in both the treated and untreated patient groups," he said. He said information on viral load is important, since "there may be a subset of patients with cirrhosis and no detectable hepatitis B virus in the blood who develop liver cancer, [and] it is difficult to recommend hepatitis B treatment in this group."

"The second major flaw is the short duration of follow-up," Bernstein said.

Still, he said, the "take-home message" from the study supports the "current standard of care, which is that all patients with liver cancer secondary to hepatitis B and detectable hepatitis B virus should be treated with oral antiviral therapy, as these therapies are safe, effective and have minimal side effects."

Another expert agreed.

"This new information is extremely valuable," said Dr. Peter Malet, director of the Center for Liver Diseases at Winthrop-University Hospital in Mineola, N.Y.

"Treatment of chronic hepatitis B with an oral medication is actually standard of care now," Malet noted, and "the available medications are taken once a day, are safe and have minimal side effects."

He said that, in most cases, insurance should cover the cost of antiviral medications. But he also stressed that most cases of primary liver cancers are not triggered by hepatitis B infection, and few liver tumors are amenable to surgery.

"The actual number of patients in the United States
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. CONRAD to host HIV symposium at 2nd Annual Antivirals Congress
2. KRAS gene mutation and amplification status affects sensitivity to antifolate therapy
3. Antibody therapy prevents gastrointestinal damage following radiation exposure in mice
4. Chemotherapy proves life-saving for some leukemia patients who fail induction therapy
5. Immunotherapy for elderly cancer patients finds new promise in drug combination
6. Therapy exploits addiction of leukemia cells
7. Intensity Modulated Radiation Therapy optimal for localized prostate cancer
8. Adding drug to standard chemotherapy provides no survival benefit for older lung cancer patients
9. Study Casts Doubt on Value of Pricey Prostate Cancer Therapy
10. 19th century therapy for Parkinsons disease may help patients today
11. New Psoriasis Drugs Not Much Better Than Standard Therapy, Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Antiviral Therapy May Cut Recurrence of Hepatitis B-Linked Liver Cancer
(Date:4/22/2014)... The latest scientific advances and emerging therapies in heart ... main annual meeting of the Heart Failure Association (HFA) ... also hear breaking news on acute heart failure during ... is part of the main congress. , The event ... the Megaron Athens International Conference Centre (MAICC). The full ...
(Date:4/22/2014)... 10 Americans support mandated coverage of birth control medications, ... the University of Michigan Health System. , Women, blacks, ... at home, and adults with private or public insurance ... universal coverage of birth control medications, according to the ... American Medical Association ( JAMA ). , Individuals ...
(Date:4/22/2014)... In parallel with modern man ( Homo sapiens ), there ... lived side by side, such as Neanderthals and the recently ... survived. What was it in our genetic makeup that ... is known about our unique genetic makeup as distinguished from ... that we are the only species among them ,to survive. ...
(Date:4/22/2014)... serious health conditions may be influenced by low exposure ... A study has revealed how men,s testosterone levels may ... some men have less of the hormone than others ... Low levels of the hormone have been linked ... shown that the cells responsible for producing testosterone in ...
(Date:4/22/2014)... more likely to have a child who develops an ... recent study from researchers from the Drexel University School ... Sweden provides more insight into how the risk associated ... and found that the risk of having a child ... older parents., In the study, published in the February ...
Breaking Medicine News(10 mins):Health News:The world's largest heart failure congress 2Health News:The world's largest heart failure congress 3Health News:More than two-thirds of Americans support mandated coverage of birth control in health plans 2Health News:What gave us the advantage over extinct types of humans? 2Health News:Child's autism risk accelerates with mother's age over 30 2Health News:Child's autism risk accelerates with mother's age over 30 3
... Lab Internacional,S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" or ... March 31, 2009. All figures included herein,were prepared ... nominal,Mexican pesos. Also, the following consolidated figures show the ... , , 1Q09 Highlights (vs. 1Q08), ...
... April 28 Claimsnet.com inc. (OTC ... solutions for the healthcare industry, today reported its results ... March 31, 2009.For the quarter ended March 31, 2009, ... from the $490,000 reported for the first quarter of ...
... The American Physical Society commends President Obama,s commitment to ... implementing policies that will enhance science and math ... 3 percent of the nation,s gross domestic product to ... ensure that the U.S. develops effective solutions to challenges ...
... battle swine flu epidemicWASHINGTON, April 28 Transportation Security Officers ... precautionary measures as they screen passengers who may have been ... Employees said today.In an urgent letter to TSA Acting Administrator ... , That a respirator, ...
... The President of the American Academy of Disaster Medicine,s ... and analysis from a disaster medicine perspective on the ... explanation of why improvements are needed to the U.S. ... any virus or pathogen; how disaster medicine specialists are ...
... CLEVELAND, April 28 DATATRAK International, Inc. (Nasdaq: ... on global eClinical solutions for the clinical trials industry, ... CRO, has become the newest member of the DATATRAK ... growing list of CROs, CPI is able to expand ...
Cached Medicine News:Health News:Genomma Lab Internacional Announces First Quarter 2009 Results 2Health News:Genomma Lab Internacional Announces First Quarter 2009 Results 3Health News:Claimsnet.com Reports First Quarter 2009 Results 2Health News:Claimsnet.com Reports First Quarter 2009 Results 3Health News:APS commends President Obama's commitment to greater investment in science 2Health News:AFGE: TSA Must Do More to Protect Its Workforce and the Public 2Health News:American Academy of Disaster Medicine's (AADM) President Comments on U.S. Public Health System, Discusses Swine Flu Infection and Prevention 2Health News:American Academy of Disaster Medicine's (AADM) President Comments on U.S. Public Health System, Discusses Swine Flu Infection and Prevention 3Health News:American Academy of Disaster Medicine's (AADM) President Comments on U.S. Public Health System, Discusses Swine Flu Infection and Prevention 4Health News:German CRO clinicalprojects international GmbH Becomes Newest Member of DATATRAK's CRO Connect Program(TM) 2Health News:German CRO clinicalprojects international GmbH Becomes Newest Member of DATATRAK's CRO Connect Program(TM) 3Health News:German CRO clinicalprojects international GmbH Becomes Newest Member of DATATRAK's CRO Connect Program(TM) 4
(Date:1/15/2014)... PHILADELPHIA , Jan. 15, 2014  Echo Therapeutics, Inc. ... company developing its Symphony® CGM System as a non-invasive, ... Robert F. Doman , Executive Chairman and Interim CEO ... Capital Markets, Tenth Annual Equity Conference. ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... report is available in its catalogue: ... India Drug Forecast and Market Analysis to ... PharmaPoint: Atopic Dermatitis - India Drug ...
(Date:1/15/2014)... Mass. , Jan. 15, 2014  Zafgen, Inc., ... unmet needs of severely obese patients, today announced ... beloranib, a selective inhibitor of methionine aminopeptidase 2 ... severe form of genetic obesity.  These results showed ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
... NEW YORK, Oct. 6, 2011 Avista Capital Partners, ... has hired Hakan Bjorklund, the departing Chief Executive Officer ... closely with Avista on the development of Nycomed during ... to Takeda Pharmaceuticals Company Limited for Euro 9.6 billion. ...
... Scios Inc. announced an agreement with the United States Department ... a prescription medication for patients with heart failure. ... guilty plea to a single misdemeanor violation of the Food, ... million fine. Scios acknowledges that NATRECOR® was misbranded ...
Cached Medicine Technology:Avista Capital Partners Appoints Hakan Bjorklund as Healthcare Operating Executive 2Avista Capital Partners Appoints Hakan Bjorklund as Healthcare Operating Executive 3
... The CELL-DYN 1800 is the latest ... technology used since the founding of the ... QC and data management capabilities, the CELL-DYN ... labs. The CELL-DYN 1800 is smaller than ...
... Precision Net Point-of-Care Data Networking ... the power of data networking. In ... results can be transferred from nursing ... laboratory. Data is instantly available to ...
... EarlyDetect® Menopause Test is a one ... menopause has occured. This test can ... follicle-stimulating hormone (FSH), which indicates whether ... simple to use and in a ...
... Teco Diagnostics manufactures fine urine chemistry ... urine chemistry reagent strips from start ... offer more economical prices compared to ... quality. Teco Diagnostics urine reagent strips ...
Medicine Products: